Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact

Condition name Status OMIM number Documents
Branchio-Oto-Renal Syndrome 1 (BOR1) approved 113650
BRCA 1 (increased susceptibility to breast cancer) approved 113705
Breast Ovarian Cancer Familial Susceptibility (BRCA2) approved 612555, 600185
Brooke-Spiegler Syndrome (BSS) approved 605041
Brugada Syndrome 1 (Sudden Unexplained Nocturnal Death Syndrome (SUNDS)) approved 601144
Calpainopathy approved 253600
Campomelic Dysplasia approved 114290
Canavan Disease approved 271900
Capillary Malformation-Arteriovenous Malformation Type 1 (CM-AVM1) approved 608354
Capillary Malformation-Arteriovenous Malformation Type 2 (CM-AVM2) approved 618196
Carney Complex approved 160980
Carnitine Acylcarnitine Translocase Deficiency (CACT) approved 212138
Cartilage-Hair Hypoplasia approved 250250
Cartilage-hair hypoplasia spectrum approved 157660
Cataract 1 (CTRCT1) approved 116200
Cataract 2 (CTRCT2) approved 604307
Cataract 4 (CTRCT4) approved 115700
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT1) approved 604772
Catecholaminergic Polymorphic Ventricular Tachycardia type 3 (CPVT3) approved 614021
Catecholaminergic Polymorphic Ventricular Tachycardia type 4 (CPVT4) approved 614916